You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH)目前尚處於投資香港藥明海德的初期 預計短期內不會產生盈利
格隆匯 02-19 17:36

格隆匯2月19日丨海利生物(603718.SH)公佈,近日有媒體報道公司參股投資的藥明海德香港有限公司WUXI VACCINES (HONG KONG) LIMITED(“香港藥明海德”)簽訂合同的事宜,現將相關情況説明如下:

1、公司目前尚處於投資香港藥明海德的初期,預計短期內不會產生盈利,對公司目前業績沒有影響。長期財務收益取決於參股公司的實際業績,暫無法預計,存在不確定性。

2、公司是香港藥明海德的參股股東,非控股股東。

3、本次合同簽署後,香港藥明海德項目建設週期較長。在合同履行過程中,存在法律、政策、技術、運營,與他人合作等相關風險,履約存在不確定性。

4、公司目前主營業務仍為獸用疫苗的研發、生產、銷售以及全資子公司上海捷門生物技術有限公司從事的醫用體外診斷試劑研究、開發、生產和銷售業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account